Ingredion Earnings Call Highlights Growth Amid Setbacks

Ingredion ((INGR)) has held its Q1 earnings call. Read on for the main highlights of the call.

Ingredion’s latest earnings call struck a cautious tone, balancing clear momentum in higher-value specialty ingredients with a sharp hit to profitability from operational setbacks. Management emphasized progress in Texture & Healthful Solutions and pea protein, along with a solid balance sheet, but repeated acknowledgments of margin compression and the Argo refinery disruption kept sentiment firmly guarded.

Stable Top Line Masks Underlying Strain

Ingredion reported Q1 2026 net sales of $1.8 billion, down just 1% year over year, demonstrating a relatively resilient revenue base despite intense operational headwinds. Beneath that stable top line, however, weaker volumes and mix in key regions hinted at tougher demand conditions and higher execution risk.

Texture & Healthful Solutions Extend Growth Streak

The Texture & Healthful Solutions segment continued to be a bright spot, logging its eighth straight quarter of volume growth with volumes up 2% and net sales up 2%. Operating income rose about 1%, helped by solutions-led sales, clean-label demand, and favorable costs and FX in certain markets, underscoring the segment’s role as Ingredion’s growth engine.

Solutions Portfolio and AI Deepen Customer Engagement

Solutions now represent roughly $1 billion of revenue, or about 40% of the segment, and are growing faster than the broader portfolio, evidencing a steadily improving mix. Management highlighted solutions-led selling and AI-enabled formulation tools that shorten the brief-to-solution cycle and tighten customer relationships, supporting premium pricing and stickier demand.

Healthful Ingredients Show Strong Structural Demand

Healthful ingredients delivered standout growth, with pea protein isolate sales surging more than 50% and stevia-based solutions rising around 6%. This strength reflects a broad shift toward protein fortification and sugar reduction across branded and private-label customers, reinforcing the strategic bet on better-for-you ingredients.

Argo Refinery Recovery Efforts Gain Traction

Following the thermal event and subsequent processing issues, Ingredion assembled a multidisciplinary team to stabilize the Argo refinery. Downstream refinery production was back to normal by quarter-end, and the company expects the corn germ processing unit to return in Q2, with event-related costs excluded from adjusted figures.

Balance Sheet Supports Ongoing Investment and Returns

Year-to-date cash from operations totaled $33 million after a planned working capital build of roughly $205 million, showing near-term cash pressure but not balance sheet stress. Ingredion invested $110 million of capital expenditure in Q1 and still returned capital through $52 million in dividends and $14 million in buybacks, supporting its long-term investment case.

Disciplined M&A and Innovation-Focused Capital

Management reiterated a disciplined approach to acquisitions, prioritizing deals that enhance Texture and Healthful Solutions capabilities rather than scale for its own sake. They also stressed that innovation and solutions-oriented investments, including AI and R&D, are ring-fenced to protect long-term competitive advantages despite near-term earnings volatility.

Operating Income Suffers a Sharp Decline

Adjusted operating income fell 22% compared with the prior year, with reported and adjusted figures at $203 million and $212 million respectively. This steep drop underscored significant margin pressure across the portfolio and marked a stark contrast with the steady revenue line.

Argo’s Cost Overrun Weighs Heavily on Results

The Argo facility issues proved far more costly than anticipated, driving roughly $40 million of negative impact in Q1 versus prior expectations of $10–$15 million. Elevated maintenance, rework, and logistics expenses from the disruption materially dragged on Food & Industrial Ingredients U.S./Canada performance and overall profitability.

U.S./Canada Food & Industrial Ingredients Underperform

Food & Industrial Ingredients U.S./Canada saw net sales drop about 9%, with volumes down around 7%, signaling both operational and demand weakness. Operating income plunged to $34 million as Argo-related costs combined with softer demand in certain food and industrial end markets to compress earnings.

Gross Margin Compression Signals Broader Pressure

Gross profit declined 14% and gross margin fell to 22.4%, reflecting the scale of operational and market challenges. The company cited Argo disruptions, lower volumes and unfavorable mix in U.S./Canada and Latin America, plus transactional FX in Mexico as primary drivers of the margin squeeze.

Latin America Hit by FX and Softer Volumes

In Latin America, Food & Industrial Ingredients net sales rose 1%, but operating income fell roughly 9% to $115 million, with margins around 20%. A stronger Mexican peso created transactional FX headwinds, while weaker volumes in Mexico and the Andean region further pressured profitability.

EPS and Cash Flow Reflect Earnings Headwinds

Adjusted diluted EPS declined by $0.63 year on year, driven by a $0.71 margin impact and a $0.14 volume impact partially offset by FX and other income. Year-to-date cash from operations of $33 million, after planned working capital investment, highlighted constrained near-term free cash flow despite ongoing growth initiatives.

Inflation and Commodity Costs Add to Volatility

Higher energy, logistics, and packaging costs, along with rapid tapioca cost inflation in Asia-Pacific, further compressed margins and added earnings volatility. While Ingredion expects to implement within-year price increases, management acknowledged that delayed pass-through and potential demand elasticity will remain key risks to near-term performance.

Guidance: Flat Sales, Lower Earnings as Argo Recovers

For 2026, Ingredion now expects full-year net sales to be flat to up low single digits and adjusted operating income to decline by high single digits, with adjusted EPS between $10.45 and $11.15. The company forecasts cash from operations of $725–$825 million and capital expenditures of $400–$440 million, assuming gradual Argo recovery, ongoing FX pressure, and elevated energy and logistics costs.

Ingredion’s call painted a picture of a company with clear strategic momentum in higher-value solutions but facing a difficult execution year. Investors will be watching closely to see if Argo normalization, pricing actions, and steady growth in healthful ingredients are enough to offset cost and FX headwinds and restore earnings momentum into 2026 and beyond.